Balchem

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Balchem reports record 2022 earnings, eyes growth amid challenges

Balchem's strong performance in 2022, driven by record sales and earnings, positions them well for future growth. Strategic acquisitions and market studies provide opportunities for expansion despite temporary challenges.

Balchem reports record Q1 revenues, navigates market challenges strategically

Balchem's Q1 2023 performance reflects solid financial results, operational efficiency, and progress in sustainability initiatives.
Despite market challenges, the company showcased resilience, innovation, and a strategic focus on long-term growth.
Opportunities for growth and differentiation exist through market expansion, product innovation, and continued sustainability efforts.
Balchem's strong financial foundation, coupled with a commitment to sustainability, underpins its strategic positioning for future success.

Balchem reports stable Q2 earnings, eyes growth in nutrition sector

Balchem delivered a mixed performance in Q2 2023 with revenue decline but improved profitability metrics.
The company faces challenges in revenue growth and leadership transition but maintains financial stability.
Opportunities lie in exploring new markets, leveraging cash reserves, and capitalizing on manufacturing investments.

Balchem (BCPC) reports solid Q3 results amid market challenges

Balchem's Q3 performance reflects resilience amidst challenges, with a focus on innovation, quality, and operational efficiency.
While facing market uncertainties and higher interest expenses, the company's strategic strengths in key segments position it for growth.
Opportunities lie in leveraging partnerships, consumer awareness efforts, and strategic initiatives to drive future sales and profitability.

Balchem reports record earnings in Q4 2023, eyes growth opportunities

Balchem's Q4 2023 performance showcased resilience with record earnings and strong profitability despite challenges in certain segments. Strategic initiatives and focus on sustainability and growth areas like Human Nutrition & Health position the company well for future success. Optimism for 2024 and potential partnerships signal a promising outlook for Balchem.

Balchem reports robust Q1 earnings, focuses on growth strategies

Balchem's Q1 2024 performance reflects strong financial results, driven by record sales and adjusted EBITDA, despite challenges in specific segments.
The company's focus on sustainability, marketing initiatives, and margin improvement positions it well for future growth and market expansion.
Addressing challenges in the Animal Nutrition & Health segment while leveraging opportunities in key segments like Human Nutrition & Health is crucial for sustained success.
Balchem's strategic partnerships, marketing efforts, and participation in investor conferences signal a proactive approach to driving growth and enhancing shareholder value.

Balchem reports solid Q2 earnings, eyes growth amid segment challenges

Balchem's Q2 2024 performance reflects resilience and growth, particularly in the Human Nutrition & Health and Specialty Products segments, despite challenges in the Animal Nutrition & Health segment.
The company's focus on innovation, debt reduction, and operational efficiency positions it well for future opportunities and sustained financial strength.
With a solid financial foundation, Balchem is poised to navigate challenges, capitalize on growth opportunities, and drive value for shareholders in the coming quarters.

Balchem (BCPC) reports record earnings, eyes growth amid margin challenges

Balchem (BCPC) delivered strong financial results in Q3 2024, driven by solid performance across its segments and successful new product launches. While anticipating margin moderation, the company remains optimistic about continued growth opportunities, especially in key segments. Balchem's focus on strategic investments and market stability positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Blachem (BCPC) Is a Great Choice for 'Trend' Investors, Here's Why

Here is how Blachem (BCPC) and L.B. Foster (FSTR) have performed compared to their sector so far this year.

Is Balchem (BCPC) Stock Outpacing Its Basic Materials Peers This Year?

If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Here's Why Momentum in Blachem (BCPC) Should Keep going

Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Blachem (BCPC) Upgraded to Strong Buy: Here's What You Should Know

MONTVALE, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 54th Annual Global Industrial Conference on November 13, 2024.

Balchem Corporation to Present at Baird's 54th Annual Global Industrial Conference on November 13, 2024

Here is how Blachem (BCPC) and Barrick Gold (GOLD) have performed compared to their sector so far this year.

Are Basic Materials Stocks Lagging Balchem (BCPC) This Year?

Balchem Corporation shows strong long-term growth potential in high-margin segments and product innovation, but faces challenges in Animal Nutrition & Health and rising costs. Balchem's financial momentum in Q3 2024 includes record earnings, improved margins, and significant debt reduction, despite missing revenue estimates. BCPC stock's high P/E ratio of 39.82x suggests big market expectations, but the current valuation may be too high given existing challenges.

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Balchem Corporation (NASDAQ:BCPC ) Q3 2024 Earnings Conference Call October 25, 2024 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, President and Chief Executive Officer Conference Call Participants Robert Labick - CJS Securities Raghuram Selvaraju - H.C. Wainwright & Co Kyle May - Sidoti and Company Operator Greetings, and welcome to the Balchem's Third Quarter 2024 Earnings Call.

Balchem Corporation (BCPC) Q3 2024 Earnings Call Transcript

Blachem (BCPC) came out with quarterly earnings of $1.03 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.90 per share a year ago.

Blachem (BCPC) Matches Q3 Earnings Estimates

MONTVALE, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal third quarter ended September 30, 2024. For the quarter, the Company reported net sales of $239.9 million, net earnings of $33.8 million, adjusted EBITDA(a) of $64.4 million, and free cash flow(a) of $42.2 million.

Balchem Corporation Reports Third Quarter 2024 Financial Results

MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review third quarter results.

Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024

All You Need to Know About Blachem (BCPC) Rating Upgrade to Strong Buy

Blachem (BCPC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

What Makes Blachem (BCPC) a Good Fit for 'Trend Investing'

Blachem (BCPC) Upgraded to Strong Buy: What Does It Mean for the Stock?

MONTVALE, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024.

Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024

Here is how Blachem (BCPC) and H. B. Fuller (FUL) have performed compared to their sector so far this year.

Is Balchem (BCPC) Outperforming Other Basic Materials Stocks This Year?

MONTVALE, N.J.--(BUSINESS WIRE)--Balchem corporation, a global manufacturer of specialty ingredients for human nutrition and health, has provided a grant to Oregon State University's Linus Pauling Institute, a leading nutrition research center in the United States. The funding, in line with Balchem's commitment to support nutrition science worldwide and increase consumer awareness on the benefits of nutrition, has enabled crucial updates to the Institute's Micronutrient Information Center. This.

Balchem Funds Critical Scientific Updates to the Linus Pauling Institute's Micronutrient Information Center

AudioEye Inc

Gorman-Rupp

Kiniksa Pharmaceuticals Ltd

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are KNSA, HNI, AEYE, BCPC, GRC.

5 Stocks With Recent Price Strength in a Volatile Market

Blachem (BCPC) is on the Move, Here's Why the Trend Could be Sustainable

Balchem Corporation (NASDAQ:BCPC ) Q2 2024 Earnings Conference Call July 26, 2024 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, President and CEO Conference Call Participants Kyle May - Sidoti and Company Ram Selvaraju - H.C. Wainwright Operator Greetings.

Balchem Corporation (BCPC) Q2 2024 Earnings Call Transcript

Blachem (BCPC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.93 per share a year ago.

Blachem (BCPC) Tops Q2 Earnings Estimates

MONTVALE, N.J., July 26, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024.

Balchem Corporation Reports Second Quarter 2024 Financial Results

Blachem (BCPC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Blachem (BCPC) Earnings Expected to Grow: Should You Buy?

Does Blachem (BCPC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Blachem (BCPC) is a Great Momentum Stock: Should You Buy?

MONTVALE, N.J., July 12, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review second quarter results.

News for Balchem Stock (BCPC)